These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany. Van Doorslaer EK, Tormans G, Gupta AK, Van Rossem K, Eggleston A, Dubois DJ, De Doncker P, Haneke E. Dermatology; 1996 Nov; 193(3):239-44. PubMed ID: 8944348 [Abstract] [Full Text] [Related]
5. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. Gupta AK. Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650 [Abstract] [Full Text] [Related]
7. Terbinafine: a review of its use in onychomycosis in adults. Darkes MJ, Scott LJ, Goa KL. Am J Clin Dermatol; 2003 Feb; 4(1):39-65. PubMed ID: 12477372 [Abstract] [Full Text] [Related]
8. Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials. Bootman JL. J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S69-72. PubMed ID: 9594941 [Abstract] [Full Text] [Related]
9. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta AK, Gover MD, Lynde CW. J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029 [Abstract] [Full Text] [Related]
10. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine. Angello JT, Voytovich RM, Jan SA. Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095 [Abstract] [Full Text] [Related]
11. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis. Gupta AK. J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408 [Abstract] [Full Text] [Related]
12. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis. Salo H, Pekurinen M. Pharmacoeconomics; 2002 May; 20(5):319-24. PubMed ID: 11994041 [Abstract] [Full Text] [Related]
13. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Sigurgeirsson B, Olafsson JH, Steinsson JB, Paul C, Billstein S, Evans EG. Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986 [Abstract] [Full Text] [Related]
14. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Casciano J, Amaya K, Doyle J, Arikian S, Shear N, Haspel M, Kahler K. Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377 [Abstract] [Full Text] [Related]
16. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. Gupta AK, Lynde CW, Konnikov N. J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119 [Abstract] [Full Text] [Related]
17. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK, Konnikov N, Lynde CW. J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [Abstract] [Full Text] [Related]